Barrett, David M.
University of Pennsylvania Perelman School of Medicine,
United States
2025 Rank: 108,740
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,980 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108,740 | 120,501 |
| Total Cites | 1,763 | 1,882 |
| H-index | 24 | 25 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 64 | 65 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 170 | 177 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,233 | 1,296 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.45 |
| Self-Citation Percentage |
6.32%
|
|
Barrett, David M.
University of Pennsylvania Perelman School of Medicine,
United States
2024 Rank: 77,366
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,551 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77,366 | 82,179 |
| Total Cites | 1,780 | 1,917 |
| H-index | 22 | 24 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 62 | 66 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 161 | 169 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,243 | 1,318 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.45 |
| Self-Citation Percentage |
7.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,324 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59,573 | 64,607 |
| Total Cites | 2,026 | 2,173 |
| H-index | 22 | 23 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 76 | 81 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 195 | 206 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,367 | 1,444 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.50 |
| Self-Citation Percentage |
6.76%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,820 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75,202 | 81,951 |
| Total Cites | 2,119 | 2,280 |
| H-index | 21 | 22 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 69 | 70 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 179 | 189 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,473 | 1,535 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.49 |
| Self-Citation Percentage |
7.06%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.